Logo image of DRMA

DERMATA THERAPEUTICS INC (DRMA) Stock Analyst Ratings

NASDAQ:DRMA - Nasdaq - US2498454055 - Common Stock - Currency: USD

0.6993  -0.02 (-2.13%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to DRMA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.06. This target is 337.58% above the current price.
DRMA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DRMA.
In the previous month the buy percentage consensus was at a similar level.
DRMA was analyzed by 7 analysts. More opinions would make the average more meaningful.
DRMA Historical Analyst RatingsDRMA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -45 -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 0.703.033.063.063.15 - 333.29% 337.58% 337.58% 350.45%
DRMA Current Analyst RatingDRMA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-05-21 Maxim Group Maintains Buy -> Buy
2024-08-21 Maxim Group Maintains Buy -> Buy
2023-03-23 Maxim Group Maintains Buy
2021-09-21 Brookline Capital Initiate Buy
2021-09-14 Maxim Group Initiate Buy